🔗 Permalink

Inventor profile of:

Henrik Sune Andersen

City:

Holte

Country:

Denmark

Published Applications:

17

Last publication date:

2020-10-01

Top Assignees for applications by Henrik Sune Andersen

The entities that hold a legal rights for patent applications filed by inventor Andersen Henrik Sune:

Novo Nordisk A/S 4 Bagsvaerd, Denmark
Novo Nordisk Health Care AG 4 Zurich, Switzerland
HIGH POINT PHARMACEUTICALS, LLC 4 High Point, NC United States
NOVO NORDISK HEALTHCARE A/G 2 Zurich, Switzerland

Recent patent applications by Andersen Henrik Sune

Henrik Sune Andersen from Holte, DK has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2020-10-01

US20200306382A1

Human necessities

Growth Hormones with Prolonged In-Vivo Efficacy

#2 | 2020-04-02

US20200102568A1

Chemistry; metallurgy

Growth Hormones with Prolonged In-Vivo Efficacy

#3 | 2019-07-04

US20190203213A1

Chemistry; metallurgy

Growth Hormones with Prolonged In-Vivo Efficacy

#4 | 2018-08-09

US20180221501A1

Human necessities

Growth Hormones with Prolonged In-Vivo Efficacy

#5 | 2017-08-24

US20170239362A1

Human necessities

Growth Hormones with Prolonged In-Vivo Efficacy

#6 | 2014-11-06

US20140329750A1

Human necessities

Growth Hormones with Prolonged In-Vivo Efficacy

#7 | 2014-10-02

US20140294853A1

Chemistry; metallurgy

Antagonistic DR3 ligands

#8 | 2014-04-17

US20140107324A1

Chemistry; metallurgy

Growth hormones with prolonged in-vivo efficacy

#9 | 2013-12-19

US20130336984A1

Chemistry; metallurgy

Antagonistic DR3 ligands

#10 | 2013-12-12

US20130330360A1

Chemistry; metallurgy

Antagonistic DR3 ligands

#11 | 2013-06-06

US20130143815A1

Chemistry; metallurgy

GROWTH HORMONE CONJUGATES

#12 | 2012-12-06

US20120309944A1

Chemistry; metallurgy

Growth hormones with prolonged in-vivo efficacy

#13 | 2012-07-05

US20120172303A1

Human necessities

Growth hormones with prolonged in-vivo efficacy

#14 | 2012-01-12

US20120010194A1

Chemistry; metallurgy

11-beta-hydroxysteroid dehydrogenase type 1 active compounds

#15 | 2012-01-05

US20120004209A1

Chemistry; metallurgy

11-Beta-Hydroxysteroid Dehydrogenase Type 1 Active Compounds

#16 | 2011-12-22

US20110312949A1

Chemistry; metallurgy

PHARMACEUTICAL USE OF SUBSTITUTED AMIDES

#17 | 2010-08-05

US20100197658A1

Chemistry; metallurgy

PHARMACEUTICAL USE OF FUSED 1,2,4-TRIAZOLES

InventorID:

275883 ⎘